PROCEPT BioRobotics Stock Pre-Market (-24%) : Q4 Revenue Miss & Weak 2026 Guidance

PRCT: PROCEPT BioRobotics logo
PRCT
PROCEPT BioRobotics

PRCT is collapsing -24% pre-market after a major Q4 revenue miss and disappointing 2026 forecast. The report has shattered growth expectations, leading to a sharp sentiment reset. Will dip-buyers see a strategic reset, or is this the start of a deeper structural decline?

This is a structural reset. PRCT missed Q4 revenue estimates by nearly $17M and guided 2026 revenue significantly below consensus, overshadowing strong procedure growth.

  • Q4 Revenue: $76.4M vs $93.7M estimate, a major top-line miss.
  • Q4 EPS: -$0.53 vs -$0.32 estimate, indicating widening losses.
  • FY 2026 Guidance: $390M-$410M, well below the consensus of $422M.

But here is the interesting part. You are reading about this -24% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to reduce exposure to losers.


Relevant Articles
  1. Could Cash Machine SBA Communications Stock Be Your Next Buy?
  2. Better Value & Growth: CP Leads Union Pacific Stock
  3. Stronger Bet Than PepsiCo Stock: KDP Delivers More
  4. Marvell’s AI Edge: 30% Growth at 26x Earnings
  5. MillerKnoll Stock To $12?
  6. EQT Looks Smarter Buy Than ConocoPhillips Stock

Trefis: PRCT Stock Insights

Playbook On Market Open

The session hinges on whether the market buys management’s ‘strategic reset’ narrative on the earnings call or views the guidance as a fundamental slowdown in growth.

  • BULL CASE: Management convinces the street this was a one-off cleanup. The stock finds a bottom and reclaims the pre-market lows.
  • BEAR CASE: Analysts slash price targets, citing a broken growth story. The stock fails to bounce and bleeds lower through the session.
  • WILD CARD: Look for commentary from the rescheduled Investor Day on Feb 26th to either stabilize or exacerbate the move.

Verdict

PIVOT: $21.00. If the stock can reclaim and hold above $21.00, the worst may be over. A break below signals capitulation and further downside is likely.
Understanding price behavior can give you an edge. See more.


Want to make sure you never miss the explainer on PRCT’s next move? Stay updated with Upcoming Events and Latest Analyses


That’s for now, but so much more goes into evaluating a stock from long-term investment perspective. We make it easy with our Investment Highlights

Smart Investing Begins With Portfolios

Single stocks swing wildly but staying invested matters. A well built portfolio helps you stay invested, captures upside and softens the blows from individual stocks.

Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.